Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07416656
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Treatment with sulfasalazine for at least 2 months prior to inclusion
* Inflammatory arthritis diagnosis (Reumatoid Arthritis, Reaktive Arthritis, Axial spa, Psoriatic spondylitis, and Juvenil artrit)
* HbA1c ≥38 mmol/mol obtained at least 2 months after sulfasalazine initiation OR a diabetes mellitus diagnosis (Type 1 diabetes mellitus, Type 2 diabetes mellitus, Malnutrition-related diabetes mellitus, Other specified diabetes mellitus (andre specificerede former for diabetes), and Unspecified diabetes mellitus (uspecificeret diabetes))
* Can communicate in Danish
* Informed consent including permission to upload glucose data and study ID to the Libreview Platform.
Exclusion Criteria:
* Systemic treatment or local injections with glucocorticoids within the previous 2 months or planned within the following 4 weeks
* Clinical conditions interfering with the interpretation of HbA1c expect for sulfasalazine alterations in red cell lifespan (etc. Dapson treatment)
* Allergy towards the adhesive used in the CGM
* Considered ineligible for participating (e.g. patients without decision-making capacity, , malignancy, terminal illness, ect.)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07416656
Study Brief:
Protocol Section:
NCT07416656